 | Up a level |
Sobolewski, Cyril; Abegg, Daniel; Berthou, Flavien; Dolicka, Dobrochna; Calo, Nicolas; Sempoux, Christine; Fournier, Margot; Maeder, Christine; Ay, Anne-Sophie; Clavien, Pierre-Alain; Humar, Bostjan; Dufour, Jean-François; Adibekian, Alexander; Foti, Michelangelo (2020). S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development. Gut, 69(10), pp. 1841-1854. BMJ Publishing Group 10.1136/gutjnl-2019-319019
